FIRST AMENDMENT AND EXTENSION OF STANDSTILL AND FORBEARANCE AGREEMENTStandstill and Forbearance Agreement • November 4th, 2020 • GT Biopharma, Inc. • Pharmaceutical preparations
This First Amendment and Extension of Standstill and Forbearance Agreement (this “Agreement”) is entered into as of October 31, 2020, by and between GT Biopharma, Inc., a Delaware corporation (the “Company”), and [●], a [●] (the “Lender”), with respect to that certain Standstill and Forbearance Agreement, dated as of June 23, 2020, between the Company and the Lender (the “Forbearance Agreement”). Any capitalized term used in this Agreement and not otherwise defined shall have the meaning ascribed to it in the Forbearance Agreement.
